Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe revision label on the page updated from v3.6.0 to v3.6.2, representing a minor version update to the interface; no study content or important functionality changes are indicated.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded recruitment status No longer looking for participants and a new revision tag v3.6.0. The earlier revision v3.5.5 was removed from the history.SummaryDifference0.2%

- Check28 days agoChange DetectedThe history now shows a new latest revision labeled v3.5.5, with the previous v3.5.4 removed from the record. This update changes the page's revision metadata rather than the study content or results.SummaryDifference0.1%

- Check49 days agoChange DetectedVersion 53 (v3.5.4) was released on 2026-05-13. It adds Contacts/Locations and Study Status sections to the study record history.SummaryDifference0.3%

- Check70 days agoChange DetectedThe page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, reflecting a backend or platform update rather than a change to the clinical trial record information.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.